Vibrio vulnificus (Reichelt et al.) Farmer emend. West et al.
商品貨號(hào)
B233013
Strain Designations
CDC 9505-95
Application
Enteric Research
Waterborne pathogen research
Isolation
Human blood; Haifa, Israel
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Preceptrol®
no
Type Strain
no
Comments
Workers with liver disease or immune deficiencies should take extra precautions. Gloves should be worn to protect against wound infection.
Medium
ATCC® Medium 2: Marine agar 2216 or marine broth 2216
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor
K Birkhead
Special Collection
NCRR Contract
Chain of Custody
ATCC <-- K Birkhead <-- E Ben-Poratch
Year of Origin
1995
References
Bisharat N, et al. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel.. Lancet 354: 1421-1424, 1999. PubMed: 10543668
